Delta “Plus”: Scientists say too early to tell risk of Covid-19 variant.
Delta plus India: Scientists say too early to tell risk of Covid-19 variant – BBC See also: There are at least 200 known cases of the Delta Plus coronavirus variant worldwide. Here’s what we know – CNN AND
The post Delta “Plus”: Scientists say too early to tell risk of Covid-19 variant. appeared first on Links Medicus.
WHO urges fully vaccinated people to continue to wear masks as delta Covid variant spreads.
WHO urges fully vaccinated people to continue to wear masks as delta Covid variant spreads – CNBC Commentary on Twitter (thread – click for more) ⚠️WEAR MASK EVEN IF VACCINATED—Top @WHO leader urges masks against #DeltaVariant even if 2-dose vaxxed. "Vaccine alone won't stop community transmission. People need to use masks consistently, be in […]
The post WHO urges fully vaccinated people to continue to wear masks as delta Covid variant spreads. appeared first on Links Medicus.
WHO: Delta variant is ‘most transmissible’ identified so far.
WHO: Delta variant is ‘most transmissible’ identified so far – Associated Press Related: Delta COVID variant fuels global surges, complicates reopenings – CIDRAP AND Delta variant triggers dangerous new phase in the pandemic – Science AND Delta coronavirus variant: scientists brace for impact – Nature AND Rapid displacement of SARS-CoV-2 variant B.1.1.7 by B.1.617.2 and […]
The post WHO: Delta variant is ‘most transmissible’ identified so far. appeared first on Links Medicus.
Phase 2 RCT: Immunogenicity and reactogenicity of a Pfizer-BioNTech booster in patients that have received a single dose of AstraZeneca vaccine – “BNT162b2 (Pfizer) given as a second dose in individuals prime vaccinated with ChAdOx1-S (AstraZeneca) induce
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial – The Lancet Commentaries: Heterologous vaccine regimens against COVID-19 – The Lancet AND Commentary on Twitter (thread – click for more) NEW #COVID19 research—Phase 2 trial by @borobia_am, @antoniojcarcaset al. reports BNT162b2 given as a 2nd […]
The post Phase 2 RCT: Immunogenicity and reactogenicity of a Pfizer-BioNTech booster in patients that have received a single dose of AstraZeneca vaccine – “BNT162b2 (Pfizer) given as a second dose in individuals prime vaccinated with ChAdOx1-S (AstraZeneca) induced a robust immune response, with an acceptable and manageable reactogenicity profile”. appeared first on Links Medicus.
Perspective | Why are people with obesity more vulnerable to COVID?
Why Are People with Obesity More Vulnerable to COVID? – Scientific American
The post Perspective | Why are people with obesity more vulnerable to COVID? appeared first on Links Medicus.
Delta COVID variant fuels global surges, complicates reopenings.
Delta COVID variant fuels global surges, complicates reopenings – CIDRAP
The post Delta COVID variant fuels global surges, complicates reopenings. appeared first on Links Medicus.
No evidence yet to suggest Covid vaccine booster is needed, CDC group says.
No evidence yet to suggest Covid vaccine booster is needed, CDC group says – NBC News Related opinion: 7 Reasons Why We Should Not Need Boosters for COVID-19 – by Monica Ghandi, MD
The post No evidence yet to suggest Covid vaccine booster is needed, CDC group says. appeared first on Links Medicus.
[Preprint] Long Covid: Third of people infected have long term symptoms.
Covid-19: Third of people infected have long term symptoms – The BMJ Original study (preprint): Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people – Imperial College London
The post [Preprint] Long Covid: Third of people infected have long term symptoms. appeared first on Links Medicus.
Long Covid: Half of young adults with COVID-19 have persistent symptoms 6 months after, study finds.
Half of young adults with COVID-19 have persistent symptoms 6 months after, study finds – The University of Bergen Original Study: Long COVID in a prospective cohort of home-isolated patients – Nature Medicine Commentary on Twitter Analysis of a prospectively enrolled cohort of patients with #SARSCoV2 infections reveals a high proportion who experienced #LongCovid […]
The post Long Covid: Half of young adults with COVID-19 have persistent symptoms 6 months after, study finds. appeared first on Links Medicus.
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis – Intensive Care Medicine Commentary on Twitter #COVID19 Associated Pulmonary Aspergillosis?increasing, associated with excess mortality?complex: colonization + tissue/angio-invasion?diagnose? bronchoscopy/BAL?antifungals recommended?consider discontinuating/tapering steroids in no respondershttps://t.co/HhS6wUfibn pic.twitter.com/CJwE3CEXxn — Intens Care Med (@yourICM) June 23, 2021
The post Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. appeared first on Links Medicus.